Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
NCT07226232
This study is recruiting at 5 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this multi-site randomized controlled trial is to evaluate the efficacy and risks of psilocybin for the treatment of depression in U.S. military Veterans with and without (±) concurrent posttraumatic stress disorder.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Major Depression
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 3
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- VA Office of Research and Development
- Last updated on ClinicalTrials.gov
- August 14, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 2
- Birmingham VA Medical Center, Birmingham, AL · Birmingham, AL
- Tuscaloosa VA Medical Center, Tuscaloosa, AL · Tuscaloosa, AL
Oregon · 1
- VA Portland Health Care System, Portland, OR · Portland, OR
Pennsylvania · 1
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA · Philadelphia, PA
Washington · 1
- VA Puget Sound Health Care System Seattle Division, Seattle, WA · Seattle, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.